Similar Stories to How Kite Pharma Could Change Cancer Treatment Forever on Bing News

Image source: Kite Pharma, Inc.Following the release of interim results from a mid stage trial, Kite Pharma, Inc. (NASDAQ: KITE) appears on track to become the first company to launch a chimeric antigen receptor T-cell, or CAR-T, therapy. If so, then the impressive efficacy observed in this trial may revolutionize how doctors tackle tough-to-treat lymphomas.Continue reading

Topics:  kite pharma   pharma    nasdaq   kite appears   t-cell   car-t   trial   
BING NEWS:
  • Kite and Sangamo come together in $3bn cancer gene editing alliance
    Two pioneers in the parallel technologies of cell therapy and gene therapy have come together in an ambitious alliance to develop new cancer ... The pharma company needs to ensure Kite generates ...
    11/10/2024 - 11:00 am | View Link
  • Great news for Kite after CAR-T success in cancer patients
    Kite looks all set ... Rosenberg and the National Cancer Institute and our ZUMA-1 clinical trial investigators who believed in the potential for CAR-T therapy to change the paradigm of cancer ...
    10/3/2024 - 1:00 pm | View Link
  • Maximizing synergy and mitigating resistance: novel dual-targeted natural killer cell therapies for cancer
    which has important inhibitory effects on NK-cell function in patients with cancer. Under the leadership of Chris Nowers, the former Head of Europe at cell therapy pioneer Kite Pharma, ONK is ...
    03/1/2021 - 3:33 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News